EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Tenax Therapeutics, Inc. (TENX) EBIT Margin data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-52.60M |
|
-- |
|
-- |
|
$56.38M |
|
$-56.38M |
|
$3.79M |
|
$-52.60M |
|
$-52.60M |
|
$-52.60M |
|
$-52.60M |
|
$-52.60M |
|
$-52.60M |
|
$-56.38M |
|
$-56.38M |
|
39.22M |
|
39.22M |
|
$-1.34 |
|
$-1.34 |
|
| Balance Sheet Financials | |
$104.23M |
|
-- |
|
-- |
|
$104.23M |
|
$7.16M |
|
-- |
|
-- |
|
$7.16M |
|
$97.07M |
|
$97.07M |
|
$97.07M |
|
9.31M |
|
| Cash Flow Statement Financials | |
$-35.80M |
|
-- |
|
$38.51M |
|
$94.85M |
|
$97.56M |
|
$2.71M |
|
$19.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-35.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.19% |
|
-54.19% |
|
-50.47% |
|
-54.19% |
|
$10.42 |
|
$-0.91 |
|
$-0.91 |
|